{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:45:08Z","timestamp":1792251908727,"version":"4.4.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.29397","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T21:36:02Z","timestamp":1634765762000},"page":"e2129397","source":"Crossref","is-referenced-by-count":49,"title":["Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome"],"prefix":"10.1001","volume":"4","author":[{"given":"Barbara","family":"Coffey","sequence":"first","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O.","family":"Claassen","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohi","family":"Jimenez-Shahed","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Gertz","sequence":"additional","affiliation":[{"name":"Nuvelution TS Pharma Inc, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Garofalo","sequence":"additional","affiliation":[{"name":"Nuvelution TS Pharma Inc, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Stamler","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wieman","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, West Chester, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha-Matti","family":"Savola","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Forrest","family":"Gordon","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, West Chester, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, West Chester, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Barkay","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Harary","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"zoi210860r1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fneur.2018.00139","article-title":"Tourette syndrome: a mini-review.","volume":"9","author":"Novotny","year":"2018","journal-title":"Front Neurol"},{"key":"zoi210860r2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fpsyt.2016.00097","article-title":"Comorbidities, social impact, and quality of life in Tourette syndrome.","volume":"7","author":"Eapen","year":"2016","journal-title":"Front Psychiatry"},{"issue":"4","key":"zoi210860r4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"7","key":"zoi210860r5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1017\/S0012162200000839","article-title":"An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries.","volume":"42","author":"Freeman","year":"2000","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"zoi210860r6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","article-title":"Practice parameter for the assessment and treatment of children and adolescents with tic disorders.","volume":"52","author":"Murphy","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"zoi210860r7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/15374410701279545","article-title":"Quality of life in youth with Tourette\u2019s syndrome and chronic tic disorder.","volume":"36","author":"Storch","year":"2007","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"5","key":"zoi210860r8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00702-019-02105-w","article-title":"Treatment of tics associated with Tourette syndrome.","volume":"127","author":"Jankovic","year":"2020","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"zoi210860r9","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s13311-020-00914-6","article-title":"Current management of tics and Tourette syndrome: behavioral, pharmacologic, and surgical treatments.","volume":"17","author":"Billnitzer","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"9","key":"zoi210860r10","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamaneurol.2018.1194","article-title":"Association of Tourette syndrome and chronic tic disorders with objective indicators of educational attainment: a population-based sibling comparison study.","volume":"75","author":"P\u00e9rez-Vigil","year":"2018","journal-title":"JAMA Neurol"},{"key":"zoi210860r11","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7424.1","article-title":"Recent advances in understanding and managing Tourette syndrome.","volume":"5","author":"Thenganatt","year":"2016","journal-title":"F1000Res"},{"issue":"1","key":"zoi210860r12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40263-017-0486-0","article-title":"Current approaches and new developments in the pharmacological management of Tourette syndrome.","volume":"32","author":"Quezada","year":"2018","journal-title":"CNS Drugs"},{"key":"zoi210860r14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.5334\/tohm.287","article-title":"Deutetrabenazine in tics associated with Tourette syndrome.","volume":"6","author":"Jankovic","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"4","key":"zoi210860r15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi210860r16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.v32.3","article-title":"Systematic review of severity scales and screening instruments for tics: Critique and recommendations.","volume":"32","author":"Martino","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"zoi210860r18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0883073816670083","article-title":"The English Version of the Gilles de la Tourette Syndrome\u2013Quality of Life Scale for Children and Adolescents (C&A-GTS-QOL).","volume":"32","author":"Su","year":"2017","journal-title":"J Child Neurol"},{"issue":"8","key":"zoi210860r19","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1007\/s10826-014-0038-x","article-title":"The children\u2019s depression inventory in worldwide child development research: a reliability generalization study.","volume":"24","author":"Sun","year":"2015","journal-title":"J Child Fam Stud"},{"issue":"12","key":"zoi210860r20","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"4","key":"zoi210860r21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1901\/jaba.2006.63-06","article-title":"Establishing the feasibility of direct observation in the assessment of tics in children with chronic tic disorders.","volume":"39","author":"Himle","year":"2006","journal-title":"J Appl Behav Anal"},{"issue":"21","key":"zoi210860r22","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/WNL.0000000000003960","article-title":"Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study.","volume":"88","author":"Fernandez","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"zoi210860r23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S2215-0366(17)30236-5","article-title":"Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.","volume":"4","author":"Anderson","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"zoi210860r24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.2016.8655","article-title":"Effect of deutetrabenazine on chorea among patients with Huntington Disease: a randomized clinical trial.","volume":"316","author":"Frank","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"zoi210860r25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.biopsych.2016.08.023","article-title":"Suicide in Tourette\u2019s and chronic tic disorders.","volume":"82","author":"Fern\u00e1ndez de la Cruz","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"10","key":"zoi210860r26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4088\/JCP.09l05669blu","article-title":"Suicide and attempted suicide in Tourette\u2019s syndrome: a case series with literature review.","volume":"71","author":"D\u00e1vila","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"zoi210860r27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jad.2016.04.027","article-title":"Suicidal ideation in youth with tic disorders.","volume":"200","author":"Johnco","year":"2016","journal-title":"J Affect Disord"},{"issue":"1","key":"zoi210860r29","article-title":"Safety and efficacy of flexible-dose deutetrabenazine in children and adolescents with Tourette syndrome: a randomized clinical trial.","volume":"4","author":"Jankovic","year":"2021","journal-title":"JAMA Netw Open"},{"key":"zoi210860r13"},{"key":"zoi210860r17","first-page":"550","volume-title":"Tourette\u2019s Syndrome and Tic Disorders","author":"Leckman","year":"1988"},{"key":"zoi210860r28","author":"Bennett","year":"2018"},{"key":"zoi210860r3","unstructured":"Centers for Disease Control and Prevention. Tourette syndrome data & statistics. Accessed August 14, 2020. https:\/\/www.cdc.gov\/ncbddd\/tourette\/data.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2785081\/coffey_2021_oi_210860_1633624168.09.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T21:36:07Z","timestamp":1634765767000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2785081"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.29397","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}